Landscape of the SOX2 protein-protein interactome

Proteomics

Volumn 11, Issue 5, 2011, Pages 921-934

  Fang, Xuefeng ^a,b,c,d   Yoon, Jae Geun ^a   Li, Lisha ^b   Tsai, Yihsuan S ^c   Zheng, Shu ^d   Hood, Leroy ^e   Goodlett, David R ^c   Foltz, Gregory ^a   Lin, Biaoyang ^a  

^a SWEDISH MEDICAL CENTER   (United States)

^b ZHEJIANG UNIVERSITY   (China)

^c UNIVERSITY OF WASHINGTON   (United States)

^d THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

Author keywords

Biomedicine; Glioblastoma multiforme; Heterogeneous nuclear ribonucleoprotein; Mass spectrometry; SOX2

Indexed keywords

HELICASE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2B1; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A3; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN C; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN L; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN M; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN R; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN U; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DNA REPAIR; EMBRYONIC STEM CELL; ENZYME ACTIVITY; GLIOBLASTOMA; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

ADULT; ANIMALS; BINDING SITES; CELL LINE, TUMOR; DNA HELICASES; DNA REPAIR; EMBRYONIC STEM CELLS; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION; GLIOBLASTOMA; HUMANS; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MICE; NEOPLASMS, NERVE TISSUE; PLURIPOTENT STEM CELLS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; RATS; RIBONUCLEOPROTEINS; RNA PROCESSING, POST-TRANSCRIPTIONAL; SOXB1 TRANSCRIPTION FACTORS;

EID: 79951730856     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201000419     Document Type: Article

References (51)

1. Avilion, A. A., Nicolis, S. K., Pevny, L. H., Perez, L. et al., Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 2003, 17, 126-140.
2. Takahashi, K., Yamanaka, S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126, 663-676.
3. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M. et al., Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131, 861-872.
4. Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J. et al., Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318, 1917-1920.
5. Giorgetti, A., Montserrat, N., Rodriguez-Piza, I., Azqueta, C. et al., Generation of induced pluripotent stem cells from human cord blood cells with only two factors: Oct4 and Sox2. Nat. Protoc. 2010, 5, 811-820.
6. Schmitz, M., Temme, A., Senner, V., Ebner, R. et al., Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy. Br. J. Cancer 2007, 96, 1293-1301.
7. Phi, J. H., Park, S. H., Kim, S. K., Paek, S. H. et al., Sox2 expression in brain tumors: a reflection of the neuroglial differentiation pathway. Am. J. Surg. Pathol. 2008, 32, 103-112.
8. Lin, B., Madan, A., Yoon, J. G., Fang, X. et al., Massively parallel signature sequencing and bioinformatics analysis identifies up-regulation of TGFBI and SOX4 in human glioblastoma. PLoS ONE 2010, 5, e10210.
9. Gangemi, R. M., Griffero, F., Marubbi, D., Perera, M. et al., SOX2 silencing in glioblastoma tumor initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells 2009, 27, 40-48.
10. Ikushima, H., Todo, T., Ino, Y., Takahashi, M. et al., Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. Cell Stem Cell 2009, 5, 504-514.
11. Shevchenko, A., Wilm, M., Vorm, O., Mann, M., Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 1996, 68, 850-858.
12. Zeeberg, B. R., Qin, H., Narasimhan, S., Sunshine, M. et al., High-throughput GoMiner, an 'industrial-strength' integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of common variable immune deficiency (CVID). BMC Bioinformatics 2005, 6, 168.
13. Dey, S., Curtis, D. J., Jane, S. M., Brandt, S. J., The TAL1/SCL transcription factor regulates cell cycle progression and proliferation in differentiating murine bone marrow monocyte precursors. Mol. Cell Biol. 2010, 30, 2181-2192.
14. Verzi, M. P., Hatzis, P., Sulahian, R., Philips, J. et al., TCF4 and CDX2, major transcription factors for intestinal function, converge on the same cis-regulatory regions. Proc. Natl. Acad. Sci. USA 2010, 107, 15157-15162.
15. Ostrowski, J., Kawata, Y., Schullery, D. S., Denisenko, O. N., Bomsztyk, K., Transient recruitment of the hnRNP K protein to inducibly transcribed gene loci. Nucleic Acids Res. 2003, 31, 3954-3962.
16. Mikula, M., Dzwonek, A., Karczmarski, J., Rubel, T. et al., Landscape of the hnRNP K protein-protein interactome. Proteomics 2006, 6, 2395-2406.
17. Cheung, H. C., Hai, T., Zhu, W., Baggerly, K. A. et al., Splicing factors PTBP1 and PTBP2 promote proliferation and migration of glioma cell lines. Brain 2009, 132, 2277-2288.
18. Faury, D., Nantel, A., Dunn, S. E., Guiot, M. C. et al., Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors. J. Clin. Oncol. 2007, 25, 1196-1208.
19. Gao, Y., Fotovati, A., Lee, C., Wang, M. et al., Inhibition of Y-box binding protein-1 slows the growth of glioblastoma multiforme and sensitizes to temozolomide independent O6-methylguanine-DNA methyltransferase. Mol. Cancer Ther. 2009, 8, 3276-3284.
20. Auboeuf, D., Dowhan, D. H., Li, X., Larkin, K. et al., CoAA, a nuclear receptor coactivator protein at the interface of transcriptional coactivation and RNA splicing. Mol. Cell Biol. 2004, 24, 442-453.
21. Brooks, Y. S., Wang, G., Yang, Z., Smith, K. K. et al., Functional pre-mRNA trans-splicing of coactivator CoAA and corepressor RBM4 during stem/progenitor cell differentiation. J. Biol. Chem. 2009, 284, 18033-18046.
22. Kang, Y. K., Schiff, R., Ko, L., Wang, T. et al., Dual roles for coactivator activator and its counterbalancing isoform coactivator modulator in human kidney cell tumorigenesis. Cancer Res. 2008, 68, 7887-7896.
23. Ramasamy, S., Wang, H., Quach, H. N., Sampath, K., Zebrafish Staufen1 and Staufen2 are required for the survival and migration of primordial germ cells. Dev. Biol. 2006, 292, 393-406.
24. Gautrey, H., McConnell, J., Lako, M., Hall, J., Hesketh, J., Staufen1 is expressed in preimplantation mouse embryos and is required for embryonic stem cell differentiation. Biochim. Biophys. Acta 2008, 1783, 1935-1942.
25. Lukong, K. E., Richard, S., Targeting the RNA-binding protein Sam68 as a treatment for cancer? Future Oncol. 2007, 3, 539-544.
26. Busa, R., Paronetto, M. P., Farini, D., Pierantozzi, E. et al., The RNA-binding protein Sam68 contributes to proliferation and survival of human prostate cancer cells. Oncogene 2007, 26, 4372-4382.
27. Abdelhaleem, M., RNA helicases: regulators of differentiation. Clin. Biochem. 2005, 38, 499-503.
28. Hu, G., Kim, J., Xu, Q., Leng, Y. et al., A genome-wide RNAi screen identifies a new transcriptional module required for self-renewal. Genes Dev. 2009, 23, 837-848.
29. Zaehres, H., Kim, J. B., Scholer, H. R., Induced pluripotent stem cells. Methods Enzymol. 2010, 476, 309-325.
30. Okita, K., Ichisaka, T., Yamanaka, S., Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448, 313-317.
31. Wernig, M., Meissner, A., Foreman, R., Brambrink, T. et al., In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007, 448, 318-324.
32. Wei, Z., Yang, Y., Zhang, P., Andrianakos, R. et al., Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming. Stem Cells 2009, 27, 2969-2978.
33. Ambrosetti, D. C., Basilico, C., Dailey, L., Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites. Mol. Cell Biol. 1997, 17, 6321-6329.
34. Wissmuller, S., Kosian, T., Wolf, M., Finzsch, M., Wegner, M., The high-mobility-group domain of Sox proteins interacts with DNA-binding domains of many transcription factors. Nucleic Acids Res. 2006, 34, 1735-1744.
35. Mallanna, S. K., Ormsbee, B. D., Iacovino, M., Gilmore, J. M. et al., Proteomic analysis of Sox2-associated proteins during early stages of mouse embryonic stem cell differentiation identifies Sox21 as a novel regulator of stem cell fate. Stem Cells 2010, 28, 1715-1727.
36. Rodda, D. J., Chew, J. L., Lim, L. H., Loh, Y. H. et al., Transcriptional regulation of nanog by OCT4 and SOX2. J. Biol. Chem. 2005, 280, 24731-24737.
37. Balzer, E., Moss, E. G., Localization of the developmental timing regulator Lin28 to mRNP complexes, P-bodies and stress granules. RNA Biol. 2007, 4, 16-25.
38. Angenstein, F., Evans, A. M., Ling, S. C., Settlage, R. E. et al., Proteomic characterization of messenger ribonucleoprotein complexes bound to nontranslated or translated poly(A) mRNAs in the rat cerebral cortex. J. Biol. Chem. 2005, 280, 6496-6503.
39. Kasyapa, C. S., Kunapuli, P., Cowell, J. K., Mass spectroscopy identifies the splicing-associated proteins, PSF, hnRNP H3, hnRNP A2/B1, and TLS/FUS as interacting partners of the ZNF198 protein associated with rearrangement in myeloproliferative disease. Exp. Cell Res. 2005, 309, 78-85.
40. Jin, S., Weaver, D. T., Double-strand break repair by Ku70 requires heterodimerization with Ku80 and DNA binding functions. EMBO J. 1997, 16, 6874-6885.
41. Rajan, P., Dalgliesh, C., Bourgeois, C. F., Heiner, M. et al., Proteomic identification of heterogeneous nuclear ribonucleoprotein L as a novel component of SLM/Sam68 Nuclear Bodies. BMC Cell Biol. 2009, 10, 82.
42. Yang, J. P., Reddy, T. R., Truong, K. T., Suhasini, M., Wong-Staal, F., Functional interaction of Sam68 and heterogeneous nuclear ribonucleoprotein K. Oncogene 2002, 21, 7187-7194.
43. Gao, J., Ade, A. S., Tarcea, V. G., Weymouth, T. E. et al., Integrating and annotating the interactome using the MiMI plugin for cytoscape. Bioinformatics 2009, 25, 137-138.
44. Cassiday, L. A., Maher, L. J., III, Having it both ways: transcription factors that bind DNA and RNA. Nucleic Acids Res. 2002, 30, 4118-4126.
45. Vousden, K. H., Prives, C., Blinded by the light: the growing complexity of p53. Cell 2009, 137, 413-431.
46. Yoshida, Y., Izumi, H., Torigoe, T., Ishiguchi, H. et al., Binding of RNA to p53 regulates its oligomerization and DNA-binding activity. Oncogene 2004, 23, 4371-4379.
47. Grinberg, S., Teiblum, G., Rahav, G., Bakhanashvili, M., p53 in cytoplasm exerts 3'→5' exonuclease activity with dsRNA. Cell Cycle 2010, 9, 2442-2455.
48. Fisher, T. S., Zakian, V. A., Ku: a multifunctional protein involved in telomere maintenance. DNA Repair (Amst) 2005, 4, 1215-1226.
49. Bertrand, P., Akhmedov, A. T., Delacote, F., Durrbach, A., Lopez, B. S., Human POMp75 is identified as the pro-oncoprotein TLS/FUS: both POMp75 and POMp100 DNA homologous pairing activities are associated to cell proliferation. Oncogene 1999, 18, 4515-4521.
50. Iko, Y., Kodama, T. S., Kasai, N., Oyama, T. et al., Domain architectures and characterization of an RNA-binding protein, TLS. J. Biol. Chem. 2004, 279, 44834-44840.
51. Tung, C. L., Hou, P. H., Kao, Y. L., Huang, Y. W. et al., SOX2 modulates alternative splicing in transitional cell carcinoma. Biochem. Biophys. Res. Commun. 2010, 393, 420-425.